A

Apex Healthcare Bhd
KLSE:AHEALTH

Watchlist Manager
Apex Healthcare Bhd
KLSE:AHEALTH
Watchlist
Price: 2.42 MYR -0.41%
Market Cap: 1.7B MYR
Have any thoughts about
Apex Healthcare Bhd?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

AHEALTH Price Targets Summary
Apex Healthcare Bhd

Wall Street analysts forecast AHEALTH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AHEALTH is 2.82 MYR with a low forecast of 2.44 MYR and a high forecast of 3.28 MYR.

AHEALTH Lowest Forecast
Wall Street Target
2.44 MYR
1% Upside
AHEALTH Average Forecast
Wall Street Target
2.82 MYR
16% Upside
AHEALTH Highest Forecast
Wall Street Target
3.28 MYR
35% Upside
Lowest
Price Target
2.44 MYR
1% Upside
Average
Price Target
2.82 MYR
16% Upside
Highest
Price Target
3.28 MYR
35% Upside
Apex Healthcare Bhd Competitors:
Price Targets
O
039200
Oscotec Inc
73% Upside
PAHC
Phibro Animal Health Corp
2% Downside
4554
Fuji Pharma Co Ltd
49% Upside
MEDCL
Medincell SA
34% Upside
O
039200
Oscotec Inc
73% Upside
PAHC
Phibro Animal Health Corp
2% Downside
4554
Fuji Pharma Co Ltd
49% Upside
MEDCL
Medincell SA
34% Upside
APLLTD
Alembic Pharmaceuticals Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
Apex Healthcare Bhd

For the last 8 years the compound annual growth rate for Apex Healthcare Bhd's revenue is 7%. The projected CAGR for the next 3 years is 5%.

7%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Apex Healthcare Bhd

For the last 8 years the compound annual growth rate for Apex Healthcare Bhd's operating income is 8%. The projected CAGR for the next 3 years is 14%.

8%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Apex Healthcare Bhd

For the last 8 years the compound annual growth rate for Apex Healthcare Bhd's net income is 36%. The projected CAGR for the next 3 years is -35%.

36%
Past Growth
-35%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

See Also

Summary
AHEALTH intrinsic value, competitors valuation, and company profile.
DCF Valuation
AHEALTH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AHEALTH stock valuation using valuation multiples.
Wall Street Estimates
AHEALTH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AHEALTH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AHEALTH's stock price target?
Price Target
2.82 MYR

According to Wall Street analysts, the average 1-year price target for AHEALTH is 2.82 MYR with a low forecast of 2.44 MYR and a high forecast of 3.28 MYR.

What is Apex Healthcare Bhd's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Apex Healthcare Bhd's revenue is 7%. The projected CAGR for the next 3 years is 5%.

What is Apex Healthcare Bhd's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Apex Healthcare Bhd's operating income is 8%. The projected CAGR for the next 3 years is 14%.

What is Apex Healthcare Bhd's Net Income forecast?
Projected CAGR
-35%

For the last 8 years the compound annual growth rate for Apex Healthcare Bhd's net income is 36%. The projected CAGR for the next 3 years is -35%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.